Shardul Amarchand Mangaldas & Co. advises Continuum Green Energy Group on the issuance of senior secured notes by its subsidiaries

Shardul Amarchand Mangaldas & Co. advised Continuum Green Energy Group (“Continuum”) on issuance of senior secured notes equivalent to U.S.$650,000,000 (“Notes”), issued by 8 subsidiaries of Continuum (“Co-Issuers”) under Regulation S/ Rule 144A of the U.S. Securities Act of 1933. The Notes are listed on the Global Securities Market of India International Exchange (IFSC) Limited… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. advised on the IPO of Emcure Pharmaceuticals Limited aggregating to ₹ 19,520 million (USD 234 million)

Shardul Amarchand Mangaldas & Co. advised Emcure Pharmaceuticals Limited (“Issuer”) on the IPO of 19,375,070 equity shares aggregating to ₹19,520.27 million (approximately USD 234 million), comprising a fresh issue of 7,946,231 equity shares aggregating to ₹8000 million and offer for sale by certain shareholders of 11,428,839 equity shares aggregating to ₹11,520.27 million (the “Offer”).  … Read More +

countinue reading

Shardul Amarchand Mangaldas and National Law School of India University invite applications for the FinTech Moot Court Competition

Shardul Amarchand Mangaldas & Co and National Law School of India University, Bengaluru, are inviting applications from law colleges across India to register for the 1st edition of ‘FinTech Moot Court Competition, 2024-2025’ in Bengaluru.   This competition, scheduled on 14th-15th September 2024 at National Law School of India University, Bengaluru campus, is set to… Read More +

countinue reading